Psychedelics not linked to mental health problems or suicidal behavior: a population study

Area of Science:

• Psychopharmacology
• Public Health
• Mental Health Research

Background:

• Psychedelic substances like LSD, psilocybin, and mescaline have a complex history.
• Concerns persist regarding their potential impact on mental health.
• Previous research has yielded mixed results on the association between psychedelic use and mental well-being.

Purpose of the Study:

• To investigate the association between lifetime psychedelic use and mental health outcomes in a large, representative sample of US adults.
• To determine if psychedelic use is an independent risk factor for serious psychological distress, mental health treatment, and suicidal behaviors.
• To evaluate the public health implications of psychedelic prohibition.

Main Methods:

• Analysis of a large dataset comprising 135,095 randomly selected US adults.
• Inclusion of 19,299 individuals who reported lifetime use of psychedelics (LSD, psilocybin, mescaline).
• Statistical adjustments for sociodemographic factors, other drug use, and history of childhood depression.

Main Results:

• No significant associations were found between lifetime psychedelic use and increased likelihood of past year serious psychological distress.
• Psychedelic use was not linked to higher rates of mental health treatment, suicidal thoughts, plans, or attempts.
• No significant associations were observed with depression or anxiety symptoms.

Conclusions:

• The study failed to find evidence that psychedelic use is an independent risk factor for mental health problems.
• Psychedelics are generally not associated with harm to brain or body organs, addiction, or compulsive use.
• The findings question the justification of psychedelic prohibition as a public health measure.